Clinical Trial Update: Endovenous Sildenafil Early Management in Newborns Pulmonary Hypertension [NA]

View source ↗

Summary

The trial evaluating intravenous sildenafil for early management of persistent pulmonary hypertension in newborns has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Pulmonary Hypertension of the Newborn

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Universidad del Norte | Conditions: Hypertension, Pulmonary | NA | Status: WITHDRAWN